**
In a significant turn of events, Grifols, the sole operator of private plasma donation clinics in Canada, has announced a temporary halt to plasma collections amid growing scrutiny over safety practices following the deaths of two donors. This decision comes shortly after a government investigation revealed potential breaches of regulatory compliance, amplifying concerns from patient advocates and the public alike.
Deaths Prompt Investigation
The tragic outcomes involved donors who experienced distress during the donation process, with the incidents occurring in October 2025 and January 2026 in Manitoba. The first victim, identified by friends as 22-year-old Rodiyat Alabede, an international student with aspirations of becoming a social worker, died shortly after her plasma donation in Winnipeg on 25 October. An autopsy ultimately attributed her death to cardiac arrest, though Health Canada has claimed it found no direct link between her death and the donation.
However, advocacy groups have raised alarms about the circumstances surrounding Alabede’s death, questioning whether she was adequately screened prior to the donation. Kat Lanteigne, a campaigner for safe blood practices, claimed that staff at the clinic lacked the necessary training to perform the procedure safely. “The failures were so egregious that … now we have more questions than answers,” she stated, highlighting the urgency of addressing these concerns.
Regulatory Oversight and Compliance Issues
In light of these incidents, Health Canada issued a formal notice of non-compliance to Grifols, revealing deficiencies in their operational practices. Inspection reports from May indicated serious lapses, including inadequate staff training, improper record-keeping, and failures to adhere to standard operating procedures. Alarmingly, the reports noted instances where staff did not cease plasma collection when alarms indicated potential issues.
Prior to this suspension, Grifols operated its clinics with the goal of facilitating plasma donations twice weekly, incentivising donors with payments of up to C$100 (£55) per session. Plasma, a crucial component of blood, is not only integral in transporting cells throughout the body but is also essential for producing medications that treat various medical conditions, including haemophilia and liver diseases.
The Response from Grifols and Health Canada
In a statement, Grifols characterised the decision to pause donations as both “proactive and voluntary,” responding to what they termed “unfounded attention” surrounding their practices. Despite the serious nature of the allegations, the company maintains that the two fatalities were not connected to the plasma donation process.
Health Canada has reassured the public that this decision will not compromise the overall safety of Canada’s blood and plasma supply. A spokesperson from the Taylor Avenue Grifols location in Winnipeg confirmed that they are collaborating with the company to rectify identified issues and ensure compliance with health standards.
The Broader Implications
These recent developments have sparked renewed discussions about the ethics of paid plasma donation clinics across Canada. While provinces like British Columbia and Quebec have banned such practices, Manitoba currently permits them, which raises questions about regulatory frameworks and donor safety.
The plasma donation process, which utilises an apheresis machine to extract blood components, is complex and time-consuming, lasting about 90 minutes compared to the standard blood donation. This heightened duration and the intricate nature of the procedure underscore the necessity for stringent safety protocols and well-trained staff.
Why it Matters
The pause in plasma donations at Grifols clinics highlights a critical intersection between public health, regulatory oversight, and ethical medical practices. As Canada grapples with the implications of these deaths, the need for robust safety measures in plasma donation becomes increasingly apparent. The tragic loss of young lives calls for a comprehensive review of operational standards across all clinics, ensuring that the health and safety of donors remain paramount. This incident not only raises alarms about current practices but also serves as a pivotal moment for the future of plasma donation in Canada, potentially reshaping policies and public perceptions.
